Treace Medical Concepts (TMCI) Reports Q2 Loss, Beats Revenue Estimates

Treace Medical Concepts (TMCI) came out with a quarterly loss of $0.28 per share versus the Zacks Consensus Estimate of a loss of $0.29. This compares to a loss of $0.34 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +3.45%. A quarter ago, it was expected that this orthopedic medical device maker would post a loss of $0.31 per share when it actually produced a loss of $0.25, delivering a surprise of +19.35%.Over the last four ...